Moderna (MRNA) PT Raised to $38 at BofA Securities

July 7, 2026 5:16 AM

BofA Securities analyst Alec Stranahan raised the price target on Moderna (NASDAQ: MRNA) to $38.00 (from $34.00) while maintaining a Underperform rating.

No results found